Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?

Mohammad Reza Edraki1, Hamid Mohammadi1, Nima Mehdizadegan1

  • 1Neonatology and Cardiac Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Insights

Kawasaki disease scores show limited accuracy in predicting coronary artery aneurysms in Iranian children. Age under one year is a risk factor for treatment resistance.

Area of Science:

  • Pediatrics
  • Cardiology
  • Rheumatology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired heart disease in children.
  • Coronary artery aneurysms (CAA) are a significant complication of KD.
  • Predictive scoring systems for CAA and treatment resistance are crucial for timely intervention.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of five established Kawasaki disease scores for predicting CAA and intravenous immunoglobulin (IVIG) resistance.
  • To assess the applicability of these scores in an Iranian pediatric population.

Main Methods:

  • A retrospective cross-sectional study of 121 pediatric KD patients.
  • Data collected included clinical, laboratory, and echocardiographic findings.
  • Five KD scores (Kobayashi, Egami, Sano, Nakano, Harada) were analyzed against CAA and IVIG resistance outcomes.

Main Results:

  • The incidence of CAA and IVIG resistance was 16.5% and 13.2%, respectively.
  • All five scores demonstrated low sensitivity for predicting CAA or IVIG resistance.
  • The Harada score had the highest sensitivity (50%) but remained below screening test criteria; other scores showed high specificity (>85%).
  • Younger age (under one year) was significantly associated with IVIG resistance.

Conclusions:

  • Established KD scoring systems have limited clinical utility for identifying high-risk Iranian children.
  • Age under one year is a significant risk factor for IVIG resistance in Kawasaki disease.
  • Further research is needed to develop culturally adapted or novel predictive tools for KD complications.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
386
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
364
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
161
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
140
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
348
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
486